论文部分内容阅读
应用storz公司生产的笑气冷凝器对28例28只眼穿透性角膜移植术后药物及常规滤过性手术不能控制眼压的青光眼施行睫状体冷冻术,并进行一年以上的随访观察。结果表明:用睫状体冷冻术治疗穿透性角膜移植术后难治性青光眼其控制眼压的有效率达89%,移植片透明率达85%,视功能的有效保存率达82%。准确把握手术时机,严恪控制冷冻温度、时间与范围,术后联合抗排斥措施是确保手术成功的关键。切忌一次冷凝过度造成眼球萎缩或一次不足便放弃治疗。
Application of storz company produced nitric oxide condenser in 28 cases of 28 eyes after penetrating keratoplasty drugs and conventional filtering surgery can not control intraocular pressure of glaucoma ciliary body cryogenic surgery and more than one year follow-up observation . The results showed that the effective rate of intraocular pressure control in refractory glaucoma after penetrating keratoplasty was 89%, the transparency rate of transplanted grafts was 85%, and the effective preservation rate of visual function was 82%. Accurate grasp of the timing of surgery, Yan Ke to control the freezing temperature, time and scope, postoperative joint anti-rejection measures to ensure the success of surgery is the key. Avoid excessive condensation caused by eyeball shrinkage or an inadequate will give up treatment.